Detalhe da pesquisa
1.
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.
Lancet Oncol
; 21(2): 207-221, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31859245
2.
ELECTROPHYSIOLOGICAL CHARACTERIZATION OF MACULAR TELANGIECTASIA TYPE 2 AND STRUCTURE-FUNCTION CORRELATION.
Retina
; 38 Suppl 1: S33-S42, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28654458
3.
Characterization of response and corneal events with extended follow-up after belantamab mafodotin (GSK2857916) monotherapy for patients with relapsed multiple myeloma: a case series from the first-time-in-human clinical trial.
Haematologica
; 105(5): e261-e263, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107339
4.
Patient-Reported Outcomes With Belantamab Mafodotin Treatment in Patients With Triple-Class Refractory Multiple Myeloma.
J Adv Pract Oncol
; 14(6): 503-518, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37808071
5.
Partial recovery of visual function in a blind patient after optogenetic therapy.
Nat Med
; 27(7): 1223-1229, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34031601
6.
Prospective exploratory study to assess the safety and efficacy of aflibercept in cystoid macular oedema associated with retinitis pigmentosa.
Br J Ophthalmol
; 104(9): 1203-1208, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32041720
7.
Progression of Retinopathy Secondary to Maternally Inherited Diabetes and Deafness - Evaluation of Predicting Parameters.
Am J Ophthalmol
; 213: 134-144, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31987901
8.
Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity.
Am J Ophthalmol
; 219: 87-100, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32446738
9.
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 447 Patients with Tubercular Intermediate Uveitis and Panuveitis.
Ocul Immunol Inflamm
; 28(sup1): 27-37, 2020 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33200957
10.
Twenty-four Month Outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: Defining the "Cure" in Ocular Tuberculosis.
Ocul Immunol Inflamm
; 28(sup1): 65-73, 2020 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32589551
11.
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Descriptive Review of Tubercular Uveitis in Paediatric Population.
Ocul Immunol Inflamm
; 28(sup1): 58-64, 2020 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32804578
12.
Visual Morbidity in Ocular Tuberculosis - Collaborative Ocular Tuberculosis Study (COTS)-1: Report #6.
Ocul Immunol Inflamm
; 28(sup1): 49-57, 2020 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32600169
13.
Tubercular Uveitis: Nuggets from Collaborative Ocular Tuberculosis Study (COTS)-1.
Ocul Immunol Inflamm
; 28(sup1): 8-16, 2020 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31763952
14.
Paracentral acute middle maculopathy following COVID-19.
Arq Bras Oftalmol
; 86(4): 397-399, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37466496
15.
High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.
Blood Cancer J
; 12(9): 128, 2022 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36064540
16.
Awareness of olfactory impairment in a cohort of patients with CNGB1-associated retinitis pigmentosa.
Eye (Lond)
; 34(4): 783-784, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31570810
17.
Repeatability of retinal thickness and volume metrics in neovascular age-related macular degeneration using the Topcon 3DOCT-1000.
Indian J Ophthalmol
; 62(9): 941-8, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25370398
18.
Paracentral acute middle maculopathy following COVID-19 / Maculopatia média aguda paracentral após a COVID-19
Arq. bras. oftalmol
; 86(4): 397-399, July-Sep. 2023. graf
Artigo
em Inglês
|
LILACS-Express
| ID: biblio-1447365
19.
Structural and functional measures of efficacy in response to bevacizumab monotherapy in diabetic macular oedema: exploratory analyses of the BOLT study (report 4).
PLoS One
; 8(8): e72755, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24013651
20.
A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.
Arch Ophthalmol
; 130(8): 972-9, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22491395